FBL and cancer: On the other hand, FBL, a well-established nucleolar methyltransferase that catalyzes the methylation of rRNA and RPs, has been linked to the enhanced resistance of cancer cells to DNA damage caused by DNA crosslinkers, i.e., cisplatin, camptothecin, and etoposide.